Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 15,000 shares at $23.00 ($345K) on 2013-12-09, disclosed to the SEC on 2013-12-11.
Scheduled sale ($345k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |